Voyager Therapeutics Ownership 2024 | Who Owns Voyager Therapeutics Now?
Institutional Ownership
30.36%
Insider Ownership
16.91%
Retail Ownership
52.73%
Institutional Holders
67.00
Voyager Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 10.86% | 0.58% | 4,672,000 | 436,000 | 10.29% | 43,496,320 | Mar 31, 2024 |
| BLACKROCK INC. | 10.22% | 0.00% | 4,397,444 | 1,764,765 | 67.03% | 40,940,205 | Mar 31, 2024 |
| ECOR1 CAPITAL, LLC | 9.11% | 0.92% | 3,917,546 | 66,039 | 1.71% | 36,472,353 | Mar 31, 2024 |
| VANGUARD GROUP INC | 7.51% | 0.00% | 3,231,698 | 702,030 | 27.75% | 30,087,109 | Mar 31, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 5.33% | 0.10% | 2,292,000 | 1,000,000 | 77.40% | 21,338,520 | Mar 31, 2024 |
| STATE STREET CORP | 4.07% | 0.00% | 1,749,168 | 1,129,356 | 182.21% | 16,284,754 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.57% | 0.00% | 1,105,555 | 173,324 | 18.59% | 10,292,717 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.42% | 0.00% | 1,041,930 | 37,144 | 3.70% | 9,702,000 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.26% | 0.00% | 972,364 | 293,486 | 43.23% | 9,054,474 | Mar 31, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 1.84% | 0.01% | 793,634 | 154,347 | 24.14% | 7,388,733 | Mar 31, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.79% | 0.00% | 769,673 | 299,444 | 63.68% | 7,165,656 | Mar 31, 2024 |
| VESTAL POINT CAPITAL, LP | 1.39% | 0.46% | 600,000 | 600,000 | 100.00% | 5,586,000 | Mar 31, 2024 |
| FEDERATED HERMES, INC. | 1.28% | 0.01% | 551,576 | - | - | 5,135,173 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.07% | 0.01% | 459,850 | 42,029 | 10.06% | 4,280,000 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.91% | 0.00% | 389,816 | 74,850 | 23.76% | 3,629,187 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.89% | 0.00% | 381,709 | 201,684 | 112.03% | 3,553,711 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.82% | 0.00% | 354,443 | 346,741 | 4501.96% | 3,299,864,000 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.74% | 0.00% | 316,655 | -6,873 | -2.12% | 2,948,058 | Mar 31, 2024 |
| GLOBEFLEX CAPITAL L P | 0.72% | 0.28% | 309,508 | -21,782 | -6.57% | 2,881,519 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | 0.70% | 0.03% | 300,000 | 300,000 | 100.00% | 2,793,000 | Mar 31, 2024 |
Voyager Therapeutics's largest institutional shareholder is ARMISTICE CAPITAL, LLC, holding 10.86% of the company's total share outstanding, currently valued at $43.50M. The top 10 institutional shareholders own together 56.19% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 9.11% | 0.92% | 3,917,546 | 66,039 | 1.71% | 36,472,353 | Mar 31, 2024 |
| ARMISTICE CAPITAL, LLC | 10.86% | 0.58% | 4,672,000 | 436,000 | 10.29% | 43,496,320 | Mar 31, 2024 |
| VESTAL POINT CAPITAL, LP | 1.39% | 0.46% | 600,000 | 600,000 | 100.00% | 5,586,000 | Mar 31, 2024 |
| SUMMERHAVEN INVESTMENT MANAGEMENT, LLC | 0.18% | 0.44% | 75,372 | 1,226 | 1.65% | 701,713 | Mar 31, 2024 |
| GLOBEFLEX CAPITAL L P | 0.72% | 0.28% | 309,508 | -21,782 | -6.57% | 2,881,519 | Mar 31, 2024 |
| ADVANTAGE ALPHA CAPITAL PARTNERS LP | 0.28% | 0.21% | 122,311 | -54,560 | -30.85% | 1,138,715 | Mar 31, 2024 |
| ALPHA DNA INVESTMENT MANAGEMENT LLC | 0.13% | 0.20% | 57,588 | 57,588 | 100.00% | 536,145 | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.21% | 0.19% | 91,534 | -94,360 | -50.76% | 852,182 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 0.42% | 0.18% | 180,857 | -125,000 | -40.87% | 1,683,779 | Mar 31, 2024 |
| HUNTER PERKINS CAPITAL MANAGEMENT, LLC | 0.15% | 0.12% | 65,165 | 65,165 | 100.00% | 607,000 | Mar 31, 2024 |
| HUSSMAN STRATEGIC ADVISORS, INC. | 0.12% | 0.11% | 52,500 | - | - | 488,775 | Mar 31, 2024 |
| CLARIVEST ASSET MANAGEMENT LLC | 0.23% | 0.10% | 100,123 | 37,275 | 59.31% | 932,145 | Mar 31, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 5.33% | 0.10% | 2,292,000 | 1,000,000 | 77.40% | 21,338,520 | Mar 31, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | 0.03% | 0.08% | 12,648 | 12,648 | 100.00% | 117,753 | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.02% | 0.08% | 10,039 | -10,684 | -51.56% | 93,463 | Mar 31, 2024 |
| VIRTUS FUND ADVISERS, LLC | 0.01% | 0.08% | 2,360 | 2,360 | 100.00% | 21,972 | Mar 31, 2024 |
| WINTON GROUP LTD | 0.17% | 0.05% | 74,511 | 28,979 | 63.65% | 693,697 | Mar 31, 2024 |
| STATE OF WYOMING | 0.07% | 0.05% | 30,948 | 4,357 | 16.39% | 288,126 | Mar 31, 2024 |
| FIDUCIARY TRUST CO | 0.60% | 0.04% | 259,397 | - | - | 2,414,986 | Mar 31, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.42% | 0.03% | 179,771 | -1,025 | -0.57% | 1,673,668 | Mar 31, 2024 |
The largest Voyager Therapeutics shareholder by % of total assets is ECOR1 CAPITAL, LLC. The company owns 3.92M shares of Voyager Therapeutics (VYGR), representing 0.92% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 10.22% | 0.00% | 4,397,444 | 1,764,765 | 67.03% | 40,940,205 | Mar 31, 2024 |
| STATE STREET CORP | 4.07% | 0.00% | 1,749,168 | 1,129,356 | 182.21% | 16,284,754 | Mar 31, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 5.33% | 0.10% | 2,292,000 | 1,000,000 | 77.40% | 21,338,520 | Mar 31, 2024 |
| VANGUARD GROUP INC | 7.51% | 0.00% | 3,231,698 | 702,030 | 27.75% | 30,087,109 | Mar 31, 2024 |
| VESTAL POINT CAPITAL, LP | 1.39% | 0.46% | 600,000 | 600,000 | 100.00% | 5,586,000 | Mar 31, 2024 |
| ARMISTICE CAPITAL, LLC | 10.86% | 0.58% | 4,672,000 | 436,000 | 10.29% | 43,496,320 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.82% | 0.00% | 354,443 | 346,741 | 4501.96% | 3,299,864,000 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | 0.70% | 0.03% | 300,000 | 300,000 | 100.00% | 2,793,000 | Mar 31, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.79% | 0.00% | 769,673 | 299,444 | 63.68% | 7,165,656 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.26% | 0.00% | 972,364 | 293,486 | 43.23% | 9,054,474 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.47% | 0.00% | 204,029 | 204,029 | 100.00% | 1,899,511 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.89% | 0.00% | 381,709 | 201,684 | 112.03% | 3,553,711 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.57% | 0.00% | 1,105,555 | 173,324 | 18.59% | 10,292,717 | Mar 31, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 1.84% | 0.01% | 793,634 | 154,347 | 24.14% | 7,388,733 | Mar 31, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.28% | 0.00% | 119,216 | 119,216 | 100.00% | 1,109,901 | Mar 31, 2024 |
| CAPTRUST FINANCIAL ADVISORS | 0.30% | 0.00% | 129,003 | 103,852 | 412.91% | 1,201,018 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.23% | 0.00% | 100,725 | 100,725 | 100.00% | 937,750 | Mar 31, 2024 |
| CITIGROUP INC | 0.25% | 0.00% | 105,593 | 100,230 | 1868.92% | 983,071 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.22% | 0.01% | 94,448 | 94,448 | 100.00% | 879,311 | Mar 31, 2024 |
| FRANKLIN RESOURCES INC | 0.25% | 0.00% | 107,921 | 93,799 | 664.20% | 1,004,744 | Mar 31, 2024 |
As of Mar 31 2024, Voyager Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 1.76M stocks of VYGR, valued at $40.94M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| D. E. SHAW & CO., INC. | 0.54% | 0.00% | 233,989 | -172,055 | -42.37% | 2,178,438 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 0.42% | 0.18% | 180,857 | -125,000 | -40.87% | 1,683,779 | Mar 31, 2024 |
| INSPIRE INVESTING, LLC | - | - | - | -95,002 | -100.00% | - | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.21% | 0.19% | 91,534 | -94,360 | -50.76% | 852,182 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.30% | 0.00% | 128,100 | -55,000 | -30.04% | 1,193,000 | Mar 31, 2024 |
| ADVANTAGE ALPHA CAPITAL PARTNERS LP | 0.28% | 0.21% | 122,311 | -54,560 | -30.85% | 1,138,715 | Mar 31, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.09% | 0.01% | 39,617 | -27,380 | -40.87% | 368,834 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.11% | 0.00% | 47,808 | -26,935 | -36.04% | 445,092 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.02% | 0.00% | 7,413 | -26,750 | -78.30% | 69,015 | Mar 31, 2024 |
| GLOBEFLEX CAPITAL L P | 0.72% | 0.28% | 309,508 | -21,782 | -6.57% | 2,881,519 | Mar 31, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -16,910 | -100.00% | - | Mar 31, 2024 |
| VESTCOR INC | 0.05% | 0.01% | 22,874 | -15,254 | -40.01% | 213,000 | Mar 31, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -14,322 | -100.00% | - | Mar 31, 2024 |
| AVIVA PLC | 0.16% | 0.00% | 70,285 | -12,498 | -15.10% | 654,353 | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.02% | 0.08% | 10,039 | -10,684 | -51.56% | 93,463 | Mar 31, 2024 |
| BARCLAYS PLC | 0.14% | 0.00% | 59,012 | -7,189 | -10.86% | 548,000 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.74% | 0.00% | 316,655 | -6,873 | -2.12% | 2,948,058 | Mar 31, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.04% | 0.00% | 15,610 | -6,320 | -28.82% | 145,329 | Mar 31, 2024 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 0.05% | 0.00% | 21,849 | -6,016 | -21.59% | 203,414,000 | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | 0.00% | 419 | -5,980 | -93.45% | 3,901 | Mar 31, 2024 |
As of Mar 31 2024, Voyager Therapeutics's biggest institutional seller is D. E. SHAW & CO., INC.. The company sold -0.17M shares of VYGR, valued at $2.18M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | 1.39% | 0.46% | 600,000 | 600,000 | 100.00% | 5,586,000 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | 0.70% | 0.03% | 300,000 | 300,000 | 100.00% | 2,793,000 | Mar 31, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.28% | 0.00% | 119,216 | 119,216 | 100.00% | 1,109,901 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.22% | 0.01% | 94,448 | 94,448 | 100.00% | 879,311 | Mar 31, 2024 |
| HUNTER PERKINS CAPITAL MANAGEMENT, LLC | 0.15% | 0.12% | 65,165 | 65,165 | 100.00% | 607,000 | Mar 31, 2024 |
| ALPHA DNA INVESTMENT MANAGEMENT LLC | 0.13% | 0.20% | 57,588 | 57,588 | 100.00% | 536,145 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.13% | 0.00% | 56,955 | 56,955 | 100.00% | 530,000 | Mar 31, 2024 |
| JANE STREET GROUP, LLC | 0.10% | 0.00% | 41,519 | 41,519 | 100.00% | 386,542 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.09% | 0.00% | 36,900 | 36,900 | 100.00% | 343,539 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.08% | 0.00% | 35,945 | 35,945 | 100.00% | 334,648 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.06% | - | 24,500 | 24,500 | 100.00% | 228,095 | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.05% | 0.00% | 21,341 | 21,341 | 100.00% | 198,685 | Mar 31, 2024 |
| PROFUND ADVISORS LLC | 0.04% | 0.01% | 18,916 | 18,916 | 100.00% | 176,108 | Mar 31, 2024 |
| JUMP FINANCIAL, LLC | 0.04% | 0.00% | 16,168 | 16,168 | 100.00% | 150,525 | Mar 31, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | 0.03% | 0.01% | 14,960 | 14,960 | 100.00% | 139,278 | Mar 31, 2024 |
| BAILARD, INC. | 0.03% | 0.00% | 13,700 | 13,700 | 100.00% | 127,547 | Mar 31, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | 0.03% | 0.08% | 12,648 | 12,648 | 100.00% | 117,753 | Mar 31, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.03% | 0.00% | 11,262 | 11,262 | 100.00% | 104,849 | Mar 31, 2024 |
| PROSHARE ADVISORS LLC | 0.03% | 0.00% | 10,876 | 10,876 | 100.00% | 101,256 | Mar 31, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | 0.02% | 0.02% | 7,593 | 7,593 | 100.00% | 70,691,000 | Mar 31, 2024 |
| PLATO INVESTMENT MANAGEMENT LTD | 0.01% | 0.00% | 4,119 | 4,119 | 100.00% | 38,348 | Mar 31, 2024 |
| VIRTUS FUND ADVISERS, LLC | 0.01% | 0.08% | 2,360 | 2,360 | 100.00% | 21,972 | Mar 31, 2024 |
| QUANTBOT TECHNOLOGIES LP | 0.00% | 0.00% | 1,500 | 1,500 | 100.00% | 13,965 | Mar 31, 2024 |
| MACROVIEW INVESTMENT MANAGEMENT LLC | 0.00% | 0.01% | 858 | 858 | 100.00% | 7,988 | Mar 31, 2024 |
| PACER ADVISORS, INC. | 0.00% | - | 554 | 554 | 100.00% | 5,158 | Mar 31, 2024 |
| DAIWA SECURITIES GROUP INC. | 0.00% | - | 201 | 201 | 100.00% | 2,000 | Mar 31, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 43 | 43 | 100.00% | 400 | Mar 31, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 33 | 33 | 100.00% | 307,000 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 6 | 6 | 100.00% | 55 | Mar 31, 2024 |
Voyager Therapeutics's largest new institutional shareholder by number of shares is VESTAL POINT CAPITAL, LP, purchased 600.00K shares, valued at $5.59M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| INSPIRE INVESTING, LLC | - | - | - | -95,002 | -100.00% | - | Mar 31, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -16,910 | -100.00% | - | Mar 31, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -14,322 | -100.00% | - | Mar 31, 2024 |
| AJOVISTA, LLC | - | - | - | -4,573 | -100.00% | - | Mar 31, 2024 |
| BENJAMIN F. EDWARDS & COMPANY, INC. | - | - | - | -2,220 | -100.00% | - | Mar 31, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -1,100 | -100.00% | - | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -135 | -100.00% | - | Mar 31, 2024 |
Voyager Therapeutics's largest sold out institutional shareholder by shares sold is INSPIRE INVESTING, LLC, sold -95.00K shares, valued at -, as of undefined.
Voyager Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Tema ETF Trust | 0.34% | 14,960 | 14,960 | - | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.22% | 534,308 | - | - | Jan 31, 2024 |
| BNY MELLON VARIABLE INVESTMENT FUND | 0.15% | 36,522 | - | - | Mar 31, 2024 |
| RMB INVESTORS TRUST | 0.14% | 75,000 | - | - | Dec 31, 2023 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.14% | 687,052 | -14,278 | -2.04% | Dec 31, 2023 |
| NEEDHAM FUNDS INC | 0.11% | 141,924 | - | - | Dec 31, 2023 |
| TOCQUEVILLE TRUST | 0.11% | 15,000 | - | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust II | 0.06% | 164,865 | - | - | Dec 31, 2023 |
| AMG FUNDS III | 0.06% | 9,799 | - | - | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.06% | 10,931 | - | - | Dec 29, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 28,600 | - | - | Dec 31, 2023 |
| BRIDGEWAY FUNDS INC | 0.06% | 138,000 | 42,519 | 44.53% | Dec 29, 2023 |
| Gabelli Healthcare & WellnessRx Trust | 0.04% | 5,000 | - | - | Dec 29, 2023 |
| IndexIQ ETF Trust | 0.04% | 89,662 | - | - | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.04% | 457,063 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.04% | 87,061 | - | - | Dec 31, 2023 |
| AMERICAN CENTURY GROWTH FUNDS, INC. | 0.03% | 5,068 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.03% | 36,525 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.02% | 34,981 | - | - | Dec 31, 2023 |
| HUSSMAN INVESTMENT TRUST | 0.01% | 52,500 | - | - | Dec 31, 2023 |
| FORUM FUNDS II | 0.01% | 11,148 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,913 | - | - | Dec 31, 2023 |
| Lattice Strategies Trust | 0.01% | 19,373 | -228 | -1.16% | Dec 31, 2023 |
| GABELLI EQUITY TRUST INC | 0.01% | 11,481 | - | - | Dec 29, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 60,352 | 5,822 | 10.68% | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.01% | 85,839 | 2,219 | 2.65% | Dec 31, 2023 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 18,186 | - | - | Mar 31, 2024 |
| UBS FUNDS | 0.01% | 35,398 | - | - | Dec 31, 2023 |
| Fidelity Commonwealth Trust II | 0.01% | 45,215 | - | - | Aug 31, 2023 |
| Principal Exchange-Traded Funds | 0.01% | 74,000 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.01% | 695,183 | 273,030 | 64.68% | Feb 29, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.01% | 5,700 | - | - | Dec 29, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 2,210,524 | 490,381 | 28.51% | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 14,649 | - | - | Feb 29, 2024 |
| SSGA FUNDS | 0.00% | 2,005 | - | - | Feb 29, 2024 |
| AMG Funds I | 0.00% | 6,507 | - | - | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 79,308 | - | - | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 842 | - | - | Dec 31, 2023 |
| JNL VARIABLE FUND LLC | 0.00% | 17,568 | - | - | Mar 31, 2020 |
| ALPS ETF Trust | 0.00% | 34,213 | -3,989 | -10.44% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 37,312 | -3 | -0.01% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 10,014 | - | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 30,556 | -434 | -1.40% | Dec 31, 2023 |
| GPS Funds I | 0.00% | 8,965 | - | - | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 299,362 | 19,304 | 6.89% | Feb 29, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 23,386 | -744 | -3.08% | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 2,623 | - | - | Dec 31, 2023 |
| AdvisorShares Trust | 0.00% | 2,800 | - | - | Dec 29, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 27,939 | - | - | Dec 31, 2023 |
| BlackRock ETF Trust | 0.00% | 718 | 407 | 130.87% | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 47,929 | - | - | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 61,723 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 281,690 | 20,844 | 7.99% | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 10,663 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 602,659 | 126,182 | 26.48% | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 107,536 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 13,268 | - | - | Dec 31, 2023 |
| SunAmerica Specialty Series | 0.00% | 213 | - | - | Apr 30, 2021 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,766 | - | - | Dec 31, 2023 |
| Virtus Strategy Trust | 0.00% | 7,788 | - | - | Dec 29, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 17,869 | -14,011 | -43.95% | Dec 31, 2023 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 4,188 | - | - | Jan 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 629 | -25,219 | -97.57% | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 26,129 | -1,016 | -3.74% | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 17,104 | - | - | Feb 29, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 200 | - | - | Dec 31, 2023 |
| Guggenheim Variable Funds Trust | 0.00% | 908 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 496 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 19,517 | 13,669 | 233.74% | Jan 31, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 4,700 | - | - | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 9,800 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 92,263 | 2,419 | 2.69% | Dec 31, 2023 |
| Meeder Funds | 0.00% | 370 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 145,952 | 17,909 | 13.99% | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 494,189 | 492,650 | 32011.05% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 290 | -3,025 | -91.25% | Dec 31, 2023 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 15,010 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund II | 0.00% | 56,000 | - | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 25,032 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 17,144 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 3,400 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 453 | 186 | 69.66% | Jan 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 1,150 | -475 | -29.23% | Dec 31, 2023 |
| PGIM ETF TRUST | 0.00% | 2,951 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,200 | - | - | Dec 29, 2023 |
| VALIC Co I | 0.00% | 12,189 | -49 | -0.40% | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 144 | - | - | Dec 31, 2023 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 102,165 | -87,015 | -46.00% | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,722 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 8,682 | 4,577 | 111.50% | Feb 29, 2024 |
| Virtus Investment Trust | 0.00% | 1,133 | - | - | Dec 29, 2023 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,685 | - | - | Dec 31, 2023 |
| WisdomTree Trust | 0.00% | 62,404 | - | - | Feb 29, 2024 |
| Pacer Funds Trust | 0.00% | 1,375 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 25,459 | - | - | Dec 29, 2023 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,265 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust I | 0.00% | 263,550 | - | - | Dec 31, 2023 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 6,066 | 6,066 | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 601 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 5,999 | 2,695 | 81.57% | Feb 29, 2024 |
Voyager Therapeutics's largest mutual fund holder by % of total assets is "Tema ETF Trust", owning 14.96K shares, compromising 0.34% of its total assets.
Voyager Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 67 | -37.38% |
| 31 Dec, 23 | 107 | -3.60% |
| 30 Sep, 23 | 111 | 4.72% |
| 30 Jun, 23 | 106 | 26.19% |
| 31 Mar, 23 | 84 | 21.74% |
| 31 Dec, 22 | 69 | 1.47% |
| 30 Sep, 22 | 68 | -9.33% |
| 30 Jun, 22 | 75 | 1.35% |
| 31 Mar, 22 | 74 | 32.14% |
| 31 Dec, 21 | 56 | -13.85% |
| 30 Sep, 21 | 65 | -10.96% |
| 30 Jun, 21 | 73 | -23.16% |
| 31 Mar, 21 | 95 | -1.04% |
| 31 Dec, 20 | 96 | -8.57% |
| 30 Sep, 20 | 105 | -3.67% |
| 30 Jun, 20 | 109 | -4.39% |
| 31 Mar, 20 | 114 | -15.56% |
| 31 Dec, 19 | 135 | 6.30% |
| 30 Sep, 19 | 127 | 2.42% |
| 30 Jun, 19 | 124 | 14.81% |
| 31 Mar, 19 | 108 | -2.70% |
| 31 Dec, 18 | 111 | -5.93% |
| 30 Sep, 18 | 118 | -5.60% |
| 30 Jun, 18 | 125 | 14.68% |
| 31 Mar, 18 | 109 | 13.54% |
| 31 Dec, 17 | 96 | 31.51% |
| 30 Sep, 17 | 73 | 43.14% |
| 30 Jun, 17 | 51 | 13.33% |
| 31 Mar, 17 | 45 | -15.09% |
| 31 Dec, 16 | 53 | 6.00% |
| 30 Sep, 16 | 50 | 2.04% |
| 30 Jun, 16 | 49 | 16.67% |
| 31 Mar, 16 | 42 | 20.00% |
| 31 Dec, 15 | 35 | - |
| 30 Jun, 10 | 1 | - |
As of 31 Mar 24, 67 institutions are holding Voyager Therapeutics's shares, representing a decrease of -37.38% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 13,062,885 | -49.46% |
| 31 Dec, 23 | 25,846,397 | -1.13% |
| 30 Sep, 23 | 26,142,796 | 1.52% |
| 30 Jun, 23 | 25,750,403 | 14.88% |
| 31 Mar, 23 | 22,414,668 | -1.23% |
| 31 Dec, 22 | 22,694,467 | -0.92% |
| 30 Sep, 22 | 22,906,109 | 0.38% |
| 30 Jun, 22 | 22,818,662 | 7.40% |
| 31 Mar, 22 | 21,245,536 | 21.07% |
| 31 Dec, 21 | 17,547,806 | -17.63% |
| 30 Sep, 21 | 21,303,821 | -5.73% |
| 30 Jun, 21 | 22,599,109 | -13.81% |
| 31 Mar, 21 | 26,219,320 | -3.84% |
| 31 Dec, 20 | 27,265,897 | -1.59% |
| 30 Sep, 20 | 27,706,154 | -5.99% |
| 30 Jun, 20 | 29,470,921 | -1.44% |
| 31 Mar, 20 | 29,901,430 | -2.02% |
| 31 Dec, 19 | 30,519,358 | 0.63% |
| 30 Sep, 19 | 30,327,583 | 4.72% |
| 30 Jun, 19 | 28,960,898 | 6.63% |
| 31 Mar, 19 | 27,159,451 | -2.21% |
| 31 Dec, 18 | 27,773,100 | -3.89% |
| 30 Sep, 18 | 28,897,112 | -0.64% |
| 30 Jun, 18 | 29,083,589 | 7.51% |
| 31 Mar, 18 | 27,053,018 | 7.73% |
| 31 Dec, 17 | 25,112,974 | 122.84% |
| 30 Sep, 17 | 11,269,635 | 2.93% |
| 30 Jun, 17 | 10,948,569 | -1.01% |
| 31 Mar, 17 | 11,060,319 | 1.15% |
| 31 Dec, 16 | 10,934,802 | 2.79% |
| 30 Sep, 16 | 10,637,832 | 0.37% |
| 30 Jun, 16 | 10,598,354 | 5.82% |
| 31 Mar, 16 | 10,015,903 | -3.72% |
| 31 Dec, 15 | 10,403,219 | - |
| 30 Jun, 10 | 1,500 | - |
Voyager Therapeutics (VYGR) has 13.06M shares outstanding as of 31 Mar 24, down -49.46% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 30.36% | 0.87% |
| 31 Dec, 23 | 58.92% | 1.63% |
| 30 Sep, 23 | 60.07% | 1.50% |
| 30 Jun, 23 | 63.37% | 2.08% |
| 31 Mar, 23 | 55.16% | 1.59% |
| 31 Dec, 22 | 58.87% | 1.66% |
| 30 Sep, 22 | 59.48% | 1.68% |
| 30 Jun, 22 | 59.58% | 1.91% |
| 31 Mar, 22 | 55.84% | 2.57% |
| 31 Dec, 21 | 46.58% | 1.47% |
| 30 Sep, 21 | 56.39% | 1.56% |
| 30 Jun, 21 | 60.13% | 1.23% |
| 31 Mar, 21 | 69.92% | 1.30% |
| 31 Dec, 20 | 73.43% | 1.33% |
| 30 Sep, 20 | 74.39% | 1.17% |
| 30 Jun, 20 | 79.59% | 1.22% |
| 31 Mar, 20 | 80.89% | 1.12% |
| 31 Dec, 19 | 85.02% | 1.25% |
| 30 Sep, 19 | 82.54% | 1.32% |
| 30 Jun, 19 | 79.10% | 1.19% |
| 31 Mar, 19 | 81.43% | 1.09% |
| 31 Dec, 18 | 86.61% | 1.07% |
| 30 Sep, 18 | 89.77% | 1.09% |
| 30 Jun, 18 | 90.95% | 1.25% |
| 31 Mar, 18 | 85.18% | 0.97% |
| 31 Dec, 17 | 93.69% | 5.05% |
| 30 Sep, 17 | 43.07% | 2.42% |
| 30 Jun, 17 | 42.20% | 2.29% |
| 31 Mar, 17 | 42.88% | 2.30% |
| 31 Dec, 16 | 43.22% | 2.46% |
| 30 Sep, 16 | 41.92% | 2.38% |
| 30 Jun, 16 | 42.01% | 2.63% |
| 31 Mar, 16 | 39.94% | 2.32% |
| 31 Dec, 15 | 41.49% | - |
| 30 Jun, 10 | 0.01% | - |
As of 31 Mar 24, Voyager Therapeutics is held by 30.36% institutional shareholders, representing a 0.87% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 48 | -4.00% |
| 31 Dec, 23 | 50 | -10.71% |
| 30 Sep, 23 | 56 | -27.27% |
| 30 Jun, 23 | 77 | 40.00% |
| 31 Mar, 23 | 55 | 77.42% |
| 31 Dec, 22 | 31 | 10.71% |
| 30 Sep, 22 | 28 | -22.22% |
| 30 Jun, 22 | 36 | -2.70% |
| 31 Mar, 22 | 37 | 60.87% |
| 31 Dec, 21 | 23 | -4.17% |
| 30 Sep, 21 | 24 | -25.00% |
| 30 Jun, 21 | 32 | -33.33% |
| 31 Mar, 21 | 48 | 20.00% |
| 31 Dec, 20 | 40 | 8.11% |
| 30 Sep, 20 | 37 | -21.28% |
| 30 Jun, 20 | 47 | -16.07% |
| 31 Mar, 20 | 56 | -22.22% |
| 31 Dec, 19 | 72 | -4.00% |
| 30 Sep, 19 | 75 | -3.85% |
| 30 Jun, 19 | 78 | 34.48% |
| 31 Mar, 19 | 58 | 11.54% |
| 31 Dec, 18 | 52 | -7.14% |
| 30 Sep, 18 | 56 | -27.27% |
| 30 Jun, 18 | 77 | 26.23% |
| 31 Mar, 18 | 61 | -18.67% |
| 31 Dec, 17 | 75 | 38.89% |
| 30 Sep, 17 | 54 | 45.95% |
| 30 Jun, 17 | 37 | 68.18% |
| 31 Mar, 17 | 22 | -26.67% |
| 31 Dec, 16 | 30 | 3.45% |
| 30 Sep, 16 | 29 | -23.68% |
| 30 Jun, 16 | 38 | 80.95% |
| 31 Mar, 16 | 21 | -40.00% |
| 31 Dec, 15 | 35 | - |
| 30 Jun, 10 | 1 | - |
48 institutional shareholders have increased their position in VYGR stock as of 31 Mar 24 compared to 50 in the previous quarter (a -4.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 11 | -65.63% |
| 31 Dec, 23 | 32 | - |
| 30 Sep, 23 | 32 | 68.42% |
| 30 Jun, 23 | 19 | 46.15% |
| 31 Mar, 23 | 13 | -23.53% |
| 31 Dec, 22 | 17 | -10.53% |
| 30 Sep, 22 | 19 | -24.00% |
| 30 Jun, 22 | 25 | 47.06% |
| 31 Mar, 22 | 17 | -19.05% |
| 31 Dec, 21 | 21 | -30.00% |
| 30 Sep, 21 | 30 | 7.14% |
| 30 Jun, 21 | 28 | -3.45% |
| 31 Mar, 21 | 29 | -12.12% |
| 31 Dec, 20 | 33 | -17.50% |
| 30 Sep, 20 | 40 | 2.56% |
| 30 Jun, 20 | 39 | 8.33% |
| 31 Mar, 20 | 36 | -7.69% |
| 31 Dec, 19 | 39 | 44.44% |
| 30 Sep, 19 | 27 | - |
| 30 Jun, 19 | 27 | -15.63% |
| 31 Mar, 19 | 32 | -5.88% |
| 31 Dec, 18 | 34 | -2.86% |
| 30 Sep, 18 | 35 | 20.69% |
| 30 Jun, 18 | 29 | - |
| 31 Mar, 18 | 29 | 107.14% |
| 31 Dec, 17 | 14 | 16.67% |
| 30 Sep, 17 | 12 | 50.00% |
| 30 Jun, 17 | 8 | -60.00% |
| 31 Mar, 17 | 20 | 53.85% |
| 31 Dec, 16 | 13 | 30.00% |
| 30 Sep, 16 | 10 | 42.86% |
| 30 Jun, 16 | 7 | -46.15% |
| 31 Mar, 16 | 13 | - |
| 31 Dec, 15 | - | - |
| 30 Jun, 10 | - | - |
11 institutional shareholders have reduced their position in VYGR stock as of 31 Mar 24 compared to 32 in the previous quarter (a -65.63% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 67 | -37.38% | 13,062,885 | -49.46% | 30.36% | 0.87% | 48 | -4.00% | 11 | -65.63% |
| 31 Dec, 23 | 107 | -3.60% | 25,846,397 | -1.13% | 58.92% | 1.63% | 50 | -10.71% | 32 | - |
| 30 Sep, 23 | 111 | 4.72% | 26,142,796 | 1.52% | 60.07% | 1.50% | 56 | -27.27% | 32 | 68.42% |
| 30 Jun, 23 | 106 | 26.19% | 25,750,403 | 14.88% | 63.37% | 2.08% | 77 | 40.00% | 19 | 46.15% |
| 31 Mar, 23 | 84 | 21.74% | 22,414,668 | -1.23% | 55.16% | 1.59% | 55 | 77.42% | 13 | -23.53% |
| 31 Dec, 22 | 69 | 1.47% | 22,694,467 | -0.92% | 58.87% | 1.66% | 31 | 10.71% | 17 | -10.53% |
| 30 Sep, 22 | 68 | -9.33% | 22,906,109 | 0.38% | 59.48% | 1.68% | 28 | -22.22% | 19 | -24.00% |
| 30 Jun, 22 | 75 | 1.35% | 22,818,662 | 7.40% | 59.58% | 1.91% | 36 | -2.70% | 25 | 47.06% |
| 31 Mar, 22 | 74 | 32.14% | 21,245,536 | 21.07% | 55.84% | 2.57% | 37 | 60.87% | 17 | -19.05% |
| 31 Dec, 21 | 56 | -13.85% | 17,547,806 | -17.63% | 46.58% | 1.47% | 23 | -4.17% | 21 | -30.00% |
| 30 Sep, 21 | 65 | -10.96% | 21,303,821 | -5.73% | 56.39% | 1.56% | 24 | -25.00% | 30 | 7.14% |
| 30 Jun, 21 | 73 | -23.16% | 22,599,109 | -13.81% | 60.13% | 1.23% | 32 | -33.33% | 28 | -3.45% |
| 31 Mar, 21 | 95 | -1.04% | 26,219,320 | -3.84% | 69.92% | 1.30% | 48 | 20.00% | 29 | -12.12% |
| 31 Dec, 20 | 96 | -8.57% | 27,265,897 | -1.59% | 73.43% | 1.33% | 40 | 8.11% | 33 | -17.50% |
| 30 Sep, 20 | 105 | -3.67% | 27,706,154 | -5.99% | 74.39% | 1.17% | 37 | -21.28% | 40 | 2.56% |
| 30 Jun, 20 | 109 | -4.39% | 29,470,921 | -1.44% | 79.59% | 1.22% | 47 | -16.07% | 39 | 8.33% |
| 31 Mar, 20 | 114 | -15.56% | 29,901,430 | -2.02% | 80.89% | 1.12% | 56 | -22.22% | 36 | -7.69% |
| 31 Dec, 19 | 135 | 6.30% | 30,519,358 | 0.63% | 85.02% | 1.25% | 72 | -4.00% | 39 | 44.44% |
| 30 Sep, 19 | 127 | 2.42% | 30,327,583 | 4.72% | 82.54% | 1.32% | 75 | -3.85% | 27 | - |
| 30 Jun, 19 | 124 | 14.81% | 28,960,898 | 6.63% | 79.10% | 1.19% | 78 | 34.48% | 27 | -15.63% |
| 31 Mar, 19 | 108 | -2.70% | 27,159,451 | -2.21% | 81.43% | 1.09% | 58 | 11.54% | 32 | -5.88% |
| 31 Dec, 18 | 111 | -5.93% | 27,773,100 | -3.89% | 86.61% | 1.07% | 52 | -7.14% | 34 | -2.86% |
| 30 Sep, 18 | 118 | -5.60% | 28,897,112 | -0.64% | 89.77% | 1.09% | 56 | -27.27% | 35 | 20.69% |
| 30 Jun, 18 | 125 | 14.68% | 29,083,589 | 7.51% | 90.95% | 1.25% | 77 | 26.23% | 29 | - |
| 31 Mar, 18 | 109 | 13.54% | 27,053,018 | 7.73% | 85.18% | 0.97% | 61 | -18.67% | 29 | 107.14% |
| 31 Dec, 17 | 96 | 31.51% | 25,112,974 | 122.84% | 93.69% | 5.05% | 75 | 38.89% | 14 | 16.67% |
| 30 Sep, 17 | 73 | 43.14% | 11,269,635 | 2.93% | 43.07% | 2.42% | 54 | 45.95% | 12 | 50.00% |
| 30 Jun, 17 | 51 | 13.33% | 10,948,569 | -1.01% | 42.20% | 2.29% | 37 | 68.18% | 8 | -60.00% |
| 31 Mar, 17 | 45 | -15.09% | 11,060,319 | 1.15% | 42.88% | 2.30% | 22 | -26.67% | 20 | 53.85% |
| 31 Dec, 16 | 53 | 6.00% | 10,934,802 | 2.79% | 43.22% | 2.46% | 30 | 3.45% | 13 | 30.00% |
| 30 Sep, 16 | 50 | 2.04% | 10,637,832 | 0.37% | 41.92% | 2.38% | 29 | -23.68% | 10 | 42.86% |
| 30 Jun, 16 | 49 | 16.67% | 10,598,354 | 5.82% | 42.01% | 2.63% | 38 | 80.95% | 7 | -46.15% |
| 31 Mar, 16 | 42 | 20.00% | 10,015,903 | -3.72% | 39.94% | 2.32% | 21 | -40.00% | 13 | - |
| 31 Dec, 15 | 35 | - | 10,403,219 | - | 41.49% | - | 35 | - | - | - |
| 30 Jun, 10 | 1 | - | 1,500 | - | 0.01% | - | 1 | - | - | - |
Voyager Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Voyager Therapeutics's stock was made by Swartz Robin on Apr 03 2024, selling 1,357 shares at $9.88 per share (valued at $13.41K).
Voyager Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 1 | 2 | 50.00% |
| Q1 2024 | 11 | 7 | 157.14% |
| Q4 2023 | 1 | 1 | 100.00% |
| Q3 2023 | 2 | 3 | 66.67% |
| Q2 2023 | 11 | 4 | 275.00% |
| Q1 2023 | 11 | 25 | 44.00% |
| Q4 2022 | 2 | - | - |
| Q3 2022 | 2 | 5 | 40.00% |
| Q2 2022 | 10 | 2 | 500.00% |
| Q1 2022 | 13 | 12 | 108.33% |
| Q4 2021 | 3 | 7 | 42.86% |
| Q2 2021 | 9 | 1 | 900.00% |
| Q1 2021 | 12 | 6 | 200.00% |
| Q3 2020 | 1 | - | - |
| Q2 2020 | 7 | 2 | 350.00% |
| Q1 2020 | 8 | 3 | 266.67% |
| Q2 2019 | 12 | - | - |
| Q1 2019 | 9 | - | - |
| Q4 2018 | 1 | - | - |
| Q3 2018 | 4 | 2 | 200.00% |
1 total buy trades, and 2 total sell trades (buy/sell ratio of 0.50%) were made by Voyager Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 2 | - |
| Q1 2024 | - | 7 | - |
| Q4 2023 | - | 1 | - |
| Q3 2023 | - | 2 | - |
| Q2 2023 | - | 3 | - |
| Q1 2023 | 1 | 23 | 4.35% |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 5 | - |
| Q2 2022 | 2 | 2 | 100.00% |
| Q1 2022 | - | 9 | - |
| Q4 2021 | - | - | - |
| Q2 2021 | - | 2 | - |
| Q1 2021 | - | 6 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | 2 | - |
| Q1 2020 | - | 3 | - |
| Q2 2019 | - | - | - |
| Q1 2019 | 1 | - | - |
| Q4 2018 | - | - | - |
| Q3 2018 | 3 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Voyager Therapeutics's stocks.
Voyager Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| TERN | Terns Pharmaceuticals, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| XFOR | X4 Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| PRQR | ProQR Therapeutics N.V. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| ARWR | Arrowhead Pharmaceuticals, Inc. |
| ANNX | Annexon, Inc. |
| PDSB | PDS Biotechnology Corporation |
| HOOK | HOOKIPA Pharma Inc. |
| LPTX | Leap Therapeutics, Inc. |
VYGR Ownership FAQ
Who Owns Voyager Therapeutics?
Voyager Therapeutics is owned by institutional shareholders (30.36%), insiders (16.91%), and public (52.73%). The largest institutional shareholder of Voyager Therapeutics is ARMISTICE CAPITAL, LLC (10.86% of total shares) and the top mutual fund owner is Tema ETF Trust (0.34% of total shares).
Who are the major institutional shareholders of Voyager Therapeutics?
Voyager Therapeutics's major institutional shareholders are ARMISTICE CAPITAL, LLC, BLACKROCK INC., ECOR1 CAPITAL, LLC, VANGUARD GROUP INC, and FARALLON CAPITAL MANAGEMENT LLC. The top five shareholders own together 43.03% of the company's share outstanding.
How many Voyager Therapeutics shareholders are there?
As of Mar 2024, there are 67 institutional shareholders of Voyager Therapeutics.
What percentage of Voyager Therapeutics is owned by ARMISTICE CAPITAL, LLC?
ARMISTICE CAPITAL, LLC owns 4.67M shares of Voyager Therapeutics, representing 10.86% of the company's total shares outstanding, valued at $43.5M (as of Mar 2024).
What percentage of Voyager Therapeutics is owned by BLACKROCK INC?
As of Mar 2024, BLACKROCK INC holds 4.4M shares of Voyager Therapeutics (VYGR), compromising 10.22% of the company, valued at $40.94M.
What percentage of Voyager Therapeutics is owned by ECOR1 CAPITAL, LLC?
ECOR1 CAPITAL, LLC is the third largest holder of Voyager Therapeutics. The company owns 3.92M of the company's shares outstanding (worth $36.47M).